Skip to content
Home
About Valeant
Key Facts and History
Board of Directors & Management
Corporate Governance
By-Laws
Governance Guidelines
Committee Structure
Committee Charters
Code of Business Conduct & Ethics
Other Ethical Disclosures
Sales & Marketing Compliance
Assistance Programs
Patient Assistance Program
Unrestricted Education Grants
Locations
Contact Us
Products & Pipeline
Dermatology
Acanya®
Atralin®
Cloderm®
Efudex/Efudix®
Oxsoralen-Ultra®
Tetrix®
Neurology
DIASTAT® AcuDial™
Migranal®
Tasmar®
Zelapar®
Consumer Brands
Kinerase®
Nyal®
Bedoyecta®
CeraVe®
Dermatix™ Ultra
Dermadrate®
Dermaveen®
Dermatix™
UV Triplegard®
Branded Generics
Development Pipeline
Dermatology Pipeline
Neurology Pipeline
Regional Expertise
Australia
Canada
Europe
Latin America
United States
Investor Relations
Stock Chart
News Releases
Financial Reports
Events & Presentations
Annual Reports
Analyst Coverage
SEC Filings
Advanced Fundamentals
Corporate Governance
Shareholder Services
Information Request
E-mail Alerts
Career Opportunities
Employee Benefits
Contact Us
Locations
Home
» Investor Relations »
Annual Reports
Investor Relations Home
Stock Chart
News Releases
Financial Reports
Events and Presentations
Annual Reports
Analyst Coverage
SEC Filings
Advanced Fundamentals
Corporate Governance
Shareholder Services
Information Request
E-mail Alerts
Annual Reports
Click on the links below to download Valeant's annual report.
2008 Annual Report
